Papers/PMID:41053771
Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial.
BMC complementary medicine and therapies2025The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
curcumin — no detected effect on visual analogue scale pain intensity
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.FindingNull result“In the between-group analysis, no significant differences were observed in VAS hand pain at rest, VAS hand pain during activity, VAS hand morning stiffness, DASH score, hand grip, pinch strength and rescue drug usage at 1, 3, and 6 months.”
Quoted verbatim from Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial.. - Study
- RCT
- Participants
- 27
- Dose
- 170 mg/day curcuminoids (turmeric powder capsules, 28.75 mg curcuminoids per capsule, two capsules three times daily) for 3 months
- Population
- patients over 50 years with hand osteoarthritis, pain during activity, between-group at 1, 3 and 6 months
Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial.2025PMID:41053771Permalink